Mano Roy, Vertosick Emily, Sankin Alexander I, Chevinsky Michael S, Larish Yaniv, Jakubowski Christopher D, Hötker Andreas M, Hakimi A Ari, Sjoberg Daniel D, Akin Oguz, Russo Paul
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Departments of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
J Urol. 2015 Mar;193(3):776-82. doi: 10.1016/j.juro.2014.09.020. Epub 2014 Sep 18.
Renal cell carcinoma most commonly metastasizes to the lung. Indeterminate pulmonary nodules develop preoperatively in half of the patients with localized renal cell carcinoma but clinical significance remains poorly defined. We determined whether the presence of indeterminate pulmonary nodules, or nodule size or number is associated with renal cell carcinoma outcomes.
We reviewed data on 1,102 patients with renal cell carcinoma in whom chest computerized tomography was done within 6 months before nephrectomy from 2002 to 2012. Patients with metastatic disease at presentation, benign tumors, pulmonary nodules greater than 2 cm or concurrent pulmonary disease were excluded, leaving 748 available for analysis. Study outcomes included lung metastasis, any distant metastasis or death from renal cell carcinoma. Cox proportional hazards models were used to assess whether the presence of indeterminate pulmonary nodules, or nodule size or number was associated with outcomes. Models were evaluated by comparing discrimination using the Harrell c-index.
Indeterminate pulmonary nodules were present in 382 of 748 patients (51%). Median followup was 4.1 years (IQR 2.2-6.1). The presence of indeterminate pulmonary nodules was not associated with distant metastasis or death from kidney cancer. However, compared to subcm indeterminate pulmonary nodules the nodules greater than 1 cm were associated with metastatic disease after adjusting for tumor histology, stage and size (HR 2.48, 95% CI 1.08-5.68, p = 0.031). The outcome c-index increased slightly after adding nodule size to a predictive model adjusted for tumor characteristics.
No evidence in the current study suggested that indeterminate pulmonary nodules less than 1 cm are associated with renal cell carcinoma progression, although large nodules significantly predicted metastatic disease. Patients with subcm indeterminate pulmonary nodules would be unlikely to benefit from extensive postoperative chest imaging surveillance, which should be reserved for patients with nodules greater than 1 cm.
肾细胞癌最常转移至肺部。半数局限性肾细胞癌患者术前会出现不明原因的肺结节,但其临床意义仍不明确。我们确定了不明原因肺结节的存在、结节大小或数量是否与肾细胞癌的预后相关。
我们回顾了2002年至2012年期间1102例肾细胞癌患者的数据,这些患者在肾切除术前6个月内进行了胸部计算机断层扫描。排除就诊时已有转移性疾病、良性肿瘤、直径大于2 cm的肺结节或并发肺部疾病的患者,最终有748例可供分析。研究结局包括肺转移、任何远处转移或肾细胞癌死亡。采用Cox比例风险模型评估不明原因肺结节的存在、结节大小或数量是否与结局相关。通过使用Harrell c指数比较鉴别能力来评估模型。
748例患者中有382例(51%)存在不明原因肺结节。中位随访时间为4.1年(四分位间距2.2 - 6.1年)。不明原因肺结节的存在与远处转移或肾癌死亡无关。然而,在调整肿瘤组织学、分期和大小后,与直径小于1 cm的不明原因肺结节相比,直径大于1 cm的结节与转移性疾病相关(风险比2.48,95%置信区间1.08 - 5.68,p = 0.031)。在针对肿瘤特征调整的预测模型中加入结节大小后,结局c指数略有增加。
本研究中没有证据表明直径小于1 cm的不明原因肺结节与肾细胞癌进展相关,尽管大结节显著预测转移性疾病。直径小于1 cm的不明原因肺结节患者不太可能从广泛的术后胸部影像学监测中获益,这种监测应保留给结节大于1 cm的患者。